Time For Independent US FDA? COVID-19 Political Pressure Reignites Debate
Executive Summary
The political spotlight on FDA during the COVID-19 pandemic has renewed the long-standing debate as to whether it should be made an independent, Cabinet-level federal agency and freed from direct HHS oversight.